 |
 |

The Lupus Band Test as a Measure of Disease Activity in Systemic Lupus Erythematosus
Poul Halberg, MD;
Susanne Ullman, MD;
Finn Jørgensen, MD
Arch Dermatol. 1982;118(8):572-576.
Abstract
One hundred twenty-seven biopsy specimens from clinically normal light-protected skin of 88 patients with active and inactive lupus erythematosus (LE) were examined for deposits of IgG, IgM, IgA, and C3 at the dermal-epidermal junction (DEJ). Deposits were found in 91% of those with active disease and in 33% of those with inactive disease. The finding of such deposits reflected active disease just as did a decrease in serum C3 and C4 levels, elevated anti-double-stranded DNA, the presence of LE cells, lymphopenia, and an elevation of the ESR. The presence or absence of deposits in repeated biopsy specimens indicated changing disease activity, as estimated clinically, just as did changes in the other variables mentioned. Neither immunoreactants in skin nor any other laboratory abnormality reflected renal disease or other type of organ involvement. Deposits of IgG were not more commonly found in patients with renal disease.
(Arch Dermatol 1982;118:572-576)
Author Affiliations
From the Medical Department, Divisions of Rheumatology (Dr Halberg) and Nephrology (Dr Jørgensen), Hvidovre Hospital; and the Department of Dermatology, Rigshospital (Dr Ullman), Copenhagen.
Footnotes
Accepted for publication Sept 15, 1981.
Reprint requests to the Department of Dermatology, Rigshospital, DK-2100 Copenhagen, Denmark (Dr Ullman).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Ultraviolet light and cutaneous lupus
Bijl and Kallenberg
Lupus 2006;15:724-727.
ABSTRACT
Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes
Reefman et al.
Rheumatology (Oxford) 2006;45:538-544.
ABSTRACT
| FULL TEXT
The composition of the lupus band test (LBT) on the sun-protected non-lesional (SPNL) skin in patients with cutaneous lupus erythematosus (CLE)
Cardinali et al.
Lupus 1999;8:755-760.
ABSTRACT
Pathology, immunopathology, and immunohistochemistry in cutaneous lupus erythematosus
David-Bajar and Davis
Lupus 1997;6:145-157.
Clinical Implications of Ribonucleoprotein Antibody
Rasmussen et al.
Arch Dermatol 1987;123:601-605.
ABSTRACT
Usefulness of Direct Immunofluorescence in Patients With Lupus Erythematosus
Dahl
Arch Dermatol 1983;119:1010-1017.
ABSTRACT
|